Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03387345 · ClinicalTrials.gov registry record · NA

Barley and Rice Mixture Effects on Blood Glucose

A NA study of Hunger and Blood Glucose, sponsored by Arizona State University.

Completed
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT03387345 is a NA study of Hunger and Blood Glucose that has completed, run by Arizona State University. The registered enrollment target is 39 participants, below the 81-participant average among 7 other Hunger trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03387345, a NA study of Hunger and Blood Glucose, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research was to investigate 5 different formulations of whole grain barley and refined white rice against a control of white bread on post-prandial glycemic response, as well as self-reported hunger/satiety in a randomized cross-over trial.

Interventions

  • OTHER 100% steel cut barley
  • OTHER 100% barley flakes
  • OTHER 50/50 rice-barley mix
  • OTHER 80/20 rice-barley mix
  • OTHER 100% rice

Study Locations (1)

Arizona

  • Arizona Biomedical Collaborative - Phoenix

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2017-02-13
Est. Completion 2017-09-18
Phase NA

Sponsor

Arizona State University

187 total trials

What the Registry Record Tells You About NCT03387345

The ClinicalTrials.gov registry entry for NCT03387345 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 7 other Hunger trials with a reported enrollment target (52% lower). The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hunger appearing as the primary indexed condition, and to 5 interventions - of which 100% steel cut barley is the first listed.

NCT03387345 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT03387345 about?

NCT03387345 is a clinical study titled "Barley and Rice Mixture Effects on Blood Glucose". The purpose of this research was to investigate 5 different formulations of whole grain barley and refined white rice against a control of white bread on post-prandial glycemic response, as well as self-reported hunger/satiety in a randomized cross-over trial.

What is the current status of trial NCT03387345?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2017-02-13. Estimated completion is 2017-09-18.

What conditions does trial NCT03387345 study?

This clinical trial studies the following conditions: Hunger, Blood Glucose, Dietary Fiber.

What interventions are being tested in trial NCT03387345?

The interventions under investigation include: 100% steel cut barley (OTHER), 100% barley flakes (OTHER), 50/50 rice-barley mix (OTHER), 80/20 rice-barley mix (OTHER), 100% rice (OTHER).

Who is sponsoring clinical trial NCT03387345?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03387345 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hunger

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.